Unit Services
The Neurochemistry Laboratory provides specialized diagnostic services in metabolic disorders, toxicology, molecular genetics, neuroimmunology, and neurodegeneration. The lab’s routine service menu is broad, spanning several diagnostic domains. Metabolic and inherited disorder screening includes amino acid and organic acid profiling by HPLC (serum, urine, and CSF), lysosomal storage disease testing (arylsulfatase, hexosaminidase, urine glycosaminoglycans/mucopolysaccharides), urinary orotic acid and organic acids, serum biotinidase, carbohydrate-deficient glycoprotein syndrome, cysteine and citrulline by HPLC, urine sulfite, thymidine phosphorylase assay, and blood beta-galactosidase. Forensic and clinical toxicology covers a wide panel including tricyclic antidepressants, benzodiazepines, barbiturates, opiates, phenothiazines, psychotropics/CNS depressants, and herbicide/pesticide screens (paraquat, diquat, chlorophenoxy compounds, irritants and corrosives), and we strengthened our abilities by working closely with the Advanced Analytical Toxicology Laboratory. Genetic and molecular diagnostics include the stroke predisposition test, APOE and LTA4H genotyping, AED resistance genetic testing, and DNA isolation services. Neuroimmunology and CNS infection markers include serum ELISA/EITB for cysticercosis, CSF oligoclonal banding, VEGF and Vitamin E assays, and immunoblots for muscle calpain and dysferlin. The dementia and neurodegeneration panel has expanded rapidly: Beta-2-transferrin (for CSF rhinorrhoea) and Phospho-Tau217 were introduced in early-to-mid 2025, and from March 2026 the lab commenced a full CSF and plasma panel—β-amyloid 1-40, 1-42, and the 1-42/1-40 ratio, total tau, phospho-tau181, and combined tau/p-tau181 and p-217/β-amyloid panels—run on the newly installed Mispa i60 CLIA platform. Altogether the department performed over 4,100 diagnostic tests in the 2025–26 year, with several of its in-house-developed markers (serum VEGF, cysticercosis EITB), which are now availed by major institutes across India, including AIIMS, New Delhi; Tata Memorial, Kolkata; Rajagiri Hospital, Aluva; St. John’s Hospital, Bangalore, etc.